Dollarphotoclub 58063672 clip
Nanopore v 500 20 1

Nanopore Diagnostics, LLC

Developing a test to rapidly diagnose bacterial infections so physicians know exactly what they are trying to treat before prescribing antibiotics.

  • Stage Product In Development
  • Industry Biotechnology
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded October 2013
  • Employees 2
  • Website

Company Summary

Our rapid bacterial diagnostic test will enable physician’s to make informed antibiotic decisions during initial patient exams. We will initially focus on severely ill sepsis patients, whose infections are life threatening and take days to diagnose currently. Opportunities for our technology platform also exist in non-clinical markets we are entering through sublicense partnerships to help fund clinical development.


  • 59dd3410 62f2 4a8b a775 a6febc0b13e4
    Co-Founder, Chief Executive Officer

    Dr. Cohen is an entrepreneur and scientist focused in the molecular diagnostic industry. He received his Ph.D. from UC San Diego where he ran a non-profit which hosted an $80k business plan competition for student-lead ventures. He then conducted his postdoctoral work in diagnostic technology development at Washington University in Saint Louis. Dr. Cohen was a 2014 fellow in the nationally-recognized Pipeline entrepreneur development program.

  • Headshot 202
    Co-Founder, board of directors

    Dr. Bausch is an entrepreneurial executive with 18 years of combined R&D and technology commercialization expertise within the biotechnology and renewable energy industries. Currently he is directing strategy and commercialization of biorefined products and technologies for POET. He is a founder of NanoporeDx and currently assists as a board member and business advisor.

  • 5bc740d1 52f0 42bb 8bc7 62ee1497b3d1
    Sr. Researcher

    Dr. Das has a biophysical and chemical engineering background spanning academic professor and industrial senior scientist positions. He has a highly relevant knowledgebase for Nanopore Diagnostics having focused his career on nanopore-based technologies and their applications.


  • Default avatar
    Brian Salmo, Polsinelli
    General Counsel
    2e5c8a3b cd1b 4f2e 88c0 734a3fef93c3
    IP Counsel
    F97ab73a 702b 411e b855 7c844e17b407
    Board Member
  • Default avatar
    Suren Dutia
    Board Member
    37954423 6a29 44ac a7fb e530c9b41d8d
    Commercialization Advisor, Strategic Partner
    80284f8d 5503 4ec3 bc78 91978e3efd87
    Scientific Advisor
  • Default avatar
    [email protected]
    Clinical Advisor